Susan Kelly

The soft tissue robotics leader looks to set itself apart from upcoming rivals with the first new da Vinci system in 10 years.

“Our top priority is restoring our earnings power, full stop,” CEO Geoff Martha said Monday at the J.P. Morgan Healthcare Conference.

An appeals court has granted Apple’s emergency motion to pause the U.S. International Trade Commission’s ban on sales of its watches with a pulse oximetry feature.

The tech giant’s move follows a USITC ruling that found the watches infringed some of Masimo’s patents for measuring blood oxygen.

Sens. Richard Durbin and Richard Blumenthal said the sleep apnea device maker “did nothing” while patients suffered.

The treatment for atrial fibrillation has gained attention as a safer alternative to radiofrequency and cryoablation. Boston Scientific and Johnson & Johnson are also pursuing the PFA market.

The DNA sequencer is preparing to unwind its 2021 acquisition of the liquid biopsy test maker while still appealing orders to do so from regulators in the U.S. and Europe.

Medtronic and Johnson & Johnson are pursuing a market that leader Boston Scientific predicts could hit $6 billion by 2030.

The ransomware group AlphV/BlackCat has claimed responsibility for the data breach and a second incident involving the company.

The $150 million fund will back early-stage companies focused on healthcare access, digital health, and precision diagnostics and interventions.